| Model Number |
CX*FX05RWA |
| Medical Device Problem Codes |
Use of Device Problem (1670); Obstruction of Flow (2423)
|
| Health Effect - Clinical Code |
Insufficient Information (4580)
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
The user facility reported that there was a membrane oxygenator clot causing system high pressure and failure to initiate cardiopulmonary bypass.The event reached the patient causing significant harm or required major intervention.The patient had venous line open and found to have obstruction to forward flow.Oxygenator was changed out prior to canceling procedure.It was unknown if the procedure was completed successfully.
|
| |
|
Additional Manufacturer Narrative
|
|
B3: date of event: requested, not provided.D6a: implanted date: device was not implanted.D6b: explanted date: device was not explanted.E1: telephone number: requested, unknown.E2: health professional: unknown.E3: occupation: administrator/ supervisor.G4: pma/510(k): k130280.The actual device has not been returned for evaluation.The investigation is currently ongoing.A follow-up report will be submitted once the investigation is complete.There was no anomaly found in the manufacturing record and the shipping inspection record of the actual product.No other similar report of the product with the involved product code/lot number was found.Terumo medical products (tmp) (importer) registration no.2243441 is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.9681834.
|
| |
|
Additional Manufacturer Narrative
|
|
This report is being submitted as follow up no.1 to provide additional information to section b5 and h6, provide a correction to sections d4 and h4, and provide the completed investigation results.The manufacturing record and the shipping inspection record of the actual product found no anomaly.No other similar report of the product with the involved product code/lot number was found.Based on the investigation result, from the additional information obtained, it was inferred that the actual product was obstructed due to the formation of blood clots.However, since the actual sample could not be investigated, it was not possible to clarify the cause of occurrence.In order to clarify the cause of occurrence, we would like to ask for your cooperation in obtaining the actual sample.The instructions for use (ifu) (capiox fx05) has the following warnings regarding blood clot formation."do not reduce heparin during circulation.Otherwise, blood clotting might occur." "adequate heparinization of the blood is required to prevent it from clotting in the system.".
|
| |
|
Event or Problem Description
|
|
Additional information was received on (b)(6) 2025: the event was recognized by the hospital as human error, not a device malfunction.It was stated that the associate set the pressure limits at 575.It was believed that he overrode the safety limits, along with other errors; therefore, he was let go.
|
| |
|
Search Alerts/Recalls
|